Cargando…
Impacts of the STING‐IFNAR1‐STAT1‐IRF1 pathway on the cellular immune reaction induced by fractionated irradiation
Radiotherapy (RT) combined with immune checkpoint inhibitors has recently produced outstanding results and is expected to be adaptable for various cancers. However, the precise molecular mechanism by which immune reactions are induced by fractionated RT is still controversial. We aimed to investigat...
Autores principales: | Du, Junyan, Kageyama, Shun‐Ichiro, Yamashita, Riu, Hirata, Hidenari, Hakozaki, Yumi, Okumura, Masayuki, Motegi, Atsushi, Hojo, Hidehiro, Nakamura, Masaki, Hirano, Yasuhiro, Sunakawa, Hironori, Minamide, Tatsunori, Kotani, Daisuke, Tanaka, Kosuke, Yano, Tomonori, Kojima, Takashi, Ohashi, Akihiro, Tsuchihara, Katsuya, Akimoto, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990811/ https://www.ncbi.nlm.nih.gov/pubmed/35133062 http://dx.doi.org/10.1111/cas.15297 |
Ejemplares similares
-
Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways
por: Du, Junyan, et al.
Publicado: (2023) -
PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
por: Kageyama, Shun-ichiro, et al.
Publicado: (2020) -
Comprehensive screening for drugs that modify radiation-induced immune responses
por: Okumura, Masayuki, et al.
Publicado: (2022) -
Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients
por: Kageyama, Shun-ichiro, et al.
Publicado: (2018) -
Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients
por: Kageyama, Shun-Ichiro, et al.
Publicado: (2018)